>

Shmuel Rubinstein - EXALENZ BIOSCIENCE Director

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>EXE</div>
  Director
Mr. Shmuel Rubinstein serves as Director at Exalenz Bioscience Ltd since September 10, 2007. He serves as Director at Madison Ltd and Bremidor Ltd. Mr. Rubinstein studied Business Management at the Wharton School of Business at the University of Pennsylvania.
Age: 78  Director Since 2007      
972 8 973 7500  http://www.exalenz.com

Management Efficiency

The company has return on total asset (ROA) of (25.36) % which means that it has lost $25.36 on every $100 spent on asset. This is way below average.
The company has accumulated 6.59 M in total debt with debt to equity ratio (D/E) of 0.18 which may suggest the company is not taking enough advantage from borrowing. EXALENZ BIOSCIENCE has Current Ratio of 1.9 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Zehavit CohenGAZIT GLOBE
2016
Joshua RosensweigTHE ISRAEL CORP
2017
Miriam HaranICL ISRAEL CHEM
2009
Orna ElovitchPeledINTERNET GOLD GOLD
2010
Amikam ShorerINTERNET GOLD GOLD
2010
Shaiy PilpelGAZIT GLOBE
2006
Yair OrglerGAZIT GLOBE
2007
Eldad BenMosheINTERNET GOLD GOLD
2010
Rosenzweig YehoshuaINTERNET GOLD GOLD
2010
Yzhak ShpunginEXPORT INVESTMENT
2015
Arieh SabanINTERNET GOLD GOLD
2005
Avisar PazICL ISRAEL CHEM
2001
Ran GuronINTERNET GOLD GOLD
2011
Yitzhak EdelmanINTERNET GOLD GOLD
2011
Rina BaumELBIT SYSTEMS LTD
2001
Michael DorGAZIT GLOBE
1999
Yehoshua GleitmanELBIT SYSTEMS LTD
2010
Ron MoskovitzICL ISRAEL CHEM
2016
Yoav DoppeltICL ISRAEL CHEM
2018
Joshua RosensweigALROV PROPERTIES
2010
Reem AminoachICL ISRAEL CHEM
2017

Company Summary

Exalenz Bioscience Ltd. develops and markets advanced tools for the diagnosing and managing liver and gastroenterology disorders in Israel. Exalenz Bioscience Ltd. is based in Modiin-Maccabim-Reut, Israel. EXALENZ BIOSCIENCE is traded on Tel Aviv Stock Exchange in Israel.EXALENZ BIOSCIENCE (EXEN) is traded on Tel Aviv Stock Exchange in Israel and employs 17 people.

EXALENZ BIOSCIENCE Leadership Team

Ilan Oren, CTOView
Susan Alpert, Vice President of RegulationView
Nachum Shamir, DirectorView
Ari Soae, Vice President-Supply ChainView
Eitan Blank, Vice President - OperationsView
Shmuel Rubinstein, DirectorView
Nisim Bilman, Vice President - Research & DevelopmentView
Saul Yemal, External DirectorView
Avi Zigelman, External DirectorView
David Stolick, CFOView
Itai Arkin, DirectorView
Sharon Kochan, External DirectorView
Gad Keren, External DirectorView
Menachem Inbar, DirectorView
Michal Hershkovitz, Vice President-Regulation & Quality AssuranceView
Raphael Werner, COOView
Einat Zisman, DirectorView
Ofer Schlesinger, Vice President - Research & DevelopmentView
Niza Lipshitz, External DirectorView
Mark Hod, Vice President of Sales, North AmericaView
Uri Geiger, Chairman of the BoardView
Roy Golan, President Vice President - FinanceView
Moshe Dori, Vice President - FinanceView

Stock Performance Indicators

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

EXALENZ BIOSCIENCE Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for FedEx and Echo Global Logistics. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Investing Opportunities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.